Global CAR T-Cell Immunotherapy Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Monotherapy
  • 1.4.3 Combination Therapy
• 1.5 Market by Application
  • 1.5.1 Global CAR T-Cell Immunotherapy Market Share by Application (2014-2025)
  • 1.5.2 Hematologic Malignancies
  • 1.5.3 Solid Malignancies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 CAR T-Cell Immunotherapy Market Size
• 2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
  • 2.2.1 CAR T-Cell Immunotherapy Market Size by Regions (2014-2025)
  • 2.2.2 CAR T-Cell Immunotherapy Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 CAR T-Cell Immunotherapy Market Size by Manufacturers
  • 3.1.1 Global CAR T-Cell Immunotherapy Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
• 3.2 CAR T-Cell Immunotherapy Key Players Head office and Area Served
• 3.3 Key Players CAR T-Cell Immunotherapy Product/Solution/Service
• 3.4 Date of Enter into CAR T-Cell Immunotherapy Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global CAR T-Cell Immunotherapy Market Size by Type (2014-2019)
• 4.2 Global CAR T-Cell Immunotherapy Market Size by Application (2014-2019)

5 United States

• 5.1 United States CAR T-Cell Immunotherapy Market Size (2014-2019)
• 5.2 CAR T-Cell Immunotherapy Key Players in United States
• 5.3 United States CAR T-Cell Immunotherapy Market Size by Type
• 5.4 United States CAR T-Cell Immunotherapy Market Size by Application

6 Europe

• 6.1 Europe CAR T-Cell Immunotherapy Market Size (2014-2019)
• 6.2 CAR T-Cell Immunotherapy Key Players in Europe
• 6.3 Europe CAR T-Cell Immunotherapy Market Size by Type
• 6.4 Europe CAR T-Cell Immunotherapy Market Size by Application

7 China

• 7.1 China CAR T-Cell Immunotherapy Market Size (2014-2019)
• 7.2 CAR T-Cell Immunotherapy Key Players in China
• 7.3 China CAR T-Cell Immunotherapy Market Size by Type
• 7.4 China CAR T-Cell Immunotherapy Market Size by Application

8 Japan

• 8.1 Japan CAR T-Cell Immunotherapy Market Size (2014-2019)
• 8.2 CAR T-Cell Immunotherapy Key Players in Japan
• 8.3 Japan CAR T-Cell Immunotherapy Market Size by Type
• 8.4 Japan CAR T-Cell Immunotherapy Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2014-2019)
• 9.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia
• 9.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type
• 9.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application

10 India

• 10.1 India CAR T-Cell Immunotherapy Market Size (2014-2019)
• 10.2 CAR T-Cell Immunotherapy Key Players in India
• 10.3 India CAR T-Cell Immunotherapy Market Size by Type
• 10.4 India CAR T-Cell Immunotherapy Market Size by Application

11 Central & South America

• 11.1 Central & South America CAR T-Cell Immunotherapy Market Size (2014-2019)
• 11.2 CAR T-Cell Immunotherapy Key Players in Central & South America
• 11.3 Central & South America CAR T-Cell Immunotherapy Market Size by Type
• 11.4 Central & South America CAR T-Cell Immunotherapy Market Size by Application

12 International Players Profiles

• 12.1 AbbVie
  • 12.1.1 AbbVie Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 CAR T-Cell Immunotherapy Introduction
  • 12.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.1.5 AbbVie Recent Development
• 12.2 Celgene
  • 12.2.1 Celgene Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 CAR T-Cell Immunotherapy Introduction
  • 12.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.2.5 Celgene Recent Development
• 12.3 Kite Pharma
  • 12.3.1 Kite Pharma Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 CAR T-Cell Immunotherapy Introduction
  • 12.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.3.5 Kite Pharma Recent Development
• 12.4 Oxford BioMedica
  • 12.4.1 Oxford BioMedica Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 CAR T-Cell Immunotherapy Introduction
  • 12.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.4.5 Oxford BioMedica Recent Development
• 12.5 Novartis
  • 12.5.1 Novartis Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 CAR T-Cell Immunotherapy Introduction
  • 12.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.5.5 Novartis Recent Development
• 12.6 Gilead
  • 12.6.1 Gilead Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 CAR T-Cell Immunotherapy Introduction
  • 12.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.6.5 Gilead Recent Development
• 12.7 Pfizer
  • 12.7.1 Pfizer Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 CAR T-Cell Immunotherapy Introduction
  • 12.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.7.5 Pfizer Recent Development
• 12.8 Cellectis
  • 12.8.1 Cellectis Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 CAR T-Cell Immunotherapy Introduction
  • 12.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.8.5 Cellectis Recent Development
• 12.9 Bellicum
  • 12.9.1 Bellicum Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 CAR T-Cell Immunotherapy Introduction
  • 12.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.9.5 Bellicum Recent Development
• 12.10 Mustang Bio
  • 12.10.1 Mustang Bio Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 CAR T-Cell Immunotherapy Introduction
  • 12.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
  • 12.10.5 Mustang Bio Recent Development
• 12.11 CARsgen Therapeutics
• 12.12 Xyphos
• 12.13 Minerva Biotechnologies
• 12.14 Adaptimmune
• 12.15 Ziopharm Oncology
• 12.16 Aurora Biopharma
• 12.17 Creative Biolabs

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer